AboutContact us
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
“Younger people are getting cancer more and more. We have to make kinder medicines.”
2
Shipping giant MSC submits bid for ZIM, challenging Hapag-Lloyd in takeover race
3
ServiceNow in advanced talks to acquire Armis at around $7 billion valuation
4
The $2.3 billion mystery arms deal Israel won’t explain
5
Armis sale to ServiceNow could yield $4 billion windfall for Insight Partners
More news

Divestment

8 stories about Divestment
אוסלו נורווגיה נורבגיה קרן העושר

Norwegian wealth fund divests from Israel’s banking sector

26.08.25|CTech
Four largest banks targeted for financing settlements; Caterpillar shares also sold.
אוסלו נורווגיה נורבגיה קרן העושר

Norway’s sovereign fund expands Israeli divestments amid Gaza war scrutiny

18.08.25|CTech, Reuters
Since late June, the fund has sold shares in 17 Israeli companies, including Paz, Azorim, Delek Motors, El Al, Energix, eToro, Max Stock, Levinsky Engineering, Priortech, Rami Levy, REIT 1, Retailors, Sela Real Estate, Amos Luzon Group Development and Energy, Firon, and Scope Metals.
הפגנה מפגינים פיטורים טבע אשדוד

With No Buyers, Teva to Close Israeli Medical Equipment Plant

09.04.18|Dror Reich
The facility in Ashdod is one of five Teva intends to sell or close in its home country
default image

Allergan to Sell Teva Shares to J.P. Morgan

14.11.17|Dror Reich and Lilach Baumer
Allergan announced it pledged its 9.8% stake in Teva to J.P. Morgan as collateral, as part of a loan agreement. The company already agreed to sell a quarter of the stock in the first quarter of 2018
מטה טבע פתח תקווה

Teva Offloads Holdings in Australia’s Mesoblast

25.10.17|Dror Reich and Lilach Baumer
The stem-cell therapy company diluted Teva’s shares through a new offering in August
אוהד שקד

Founding Family Sells Holdings in Online Gambling Company 888

09.10.17|Golan Hazani and Lilach Baumer
Co-founder Aaron Shaked’s heirs sold their entire stake for nearly $300 million
חברת ה תרופות טבע Teva

Teva Sells Remaining Women's Health Assets

18.09.17|Lilach Baumer
After selling its Paragard business for $1.1 billion last week, Teva's remaining Women's Health business will be split between CVC Capital Partners and Foundation Consumer Healthcare in a $1.38 billion cash deal
מפעל חברת טבע הר חוצבים ירושלים

Teva Negotiating Sale of Remaining Women's Health Assets, Report Says

14.09.17|Lilach Baumer
CVC Capital Partners is nearing a $800 million deal for Teva's remaining Women's Health business, Bloomberg reported Thursday